Baylis Medical Co., Inc.: FDA filings under this applicant name
FDA lists 53 510(k) clearances under 3 spellings of the applicant name “Baylis Medical Co., Inc.” (first 1998, latest 2025), across 15 product codes in 6 review panels. Median 510(k) review time under this name: 100 days. Since 2017 the median was 154 days, against 111 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Boston Scientific, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 2 | 193 |
| 2013 | 2 | 76 |
| 2014 | 0 | — |
| 2015 | 4 | 124 |
| 2016 | 1 | 80 |
| 2017 | 1 | 200 |
| 2018 | 0 | — |
| 2019 | 7 | 163 |
| 2020 | 1 | 29 |
| 2021 | 0 | — |
| 2022 | 3 | 223 |
| 2023 | 3 | 236 |
| 2024 | 2 | 68 |
| 2025 | 1 | 30 |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Baylis Medical Co., Inc. took a median 154 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 111 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| GEI | Electrosurgical, Cutting & Coagulation & Accessories | 11 | 11 |
| DYB | Introducer, Catheter | 8 | 8 |
| GXI | Probe, Radiofrequency Lesion | 7 | 7 |
| DRE | Dilator, Vessel, For Percutaneous Catheterization | 5 | 5 |
| DXF | Catheter, Septostomy | 5 | 5 |
| DQX | Wire, Guide, Catheter | 3 | 3 |
| GXD | Generator, Lesion, Radiofrequency | 3 | 3 |
| DRF | Catheter, Electrode Recording, Or Probe, Electrode Recording | 2 | 2 |
| HRX | Arthroscope | 2 | 2 |
| PDU | Catheter For Crossing Total Occlusions | 2 | 2 |
Plus 5 more product codes.
Review panels
- Cardiovascular (27)
- General and Plastic Surgery (12)
- Neurology (10)
- Orthopedic (2)
- General Hospital (1)
- Immunology (1)
Most recent Baylis Medical Co., Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K251325 | VersaCross Connect Transseptal Dilator | DRE | 2025-05-29 | 30 |
| K242076 | VersaCross RF Wire | DXF | 2024-11-01 | 108 |
| K241720 | VersaCross Connect Transseptal Dilator | DRE | 2024-07-12 | 28 |
| K231227 | SureFlex HD Steerable Sheath, VersaCross HD Steerable Sheath | DYB | 2023-12-20 | 236 |
| K233647 | VersaCross Connect Transseptal Dilator | DRE | 2023-12-14 | 30 |
| K213898 | ProTrack Pigtail Wire | DQX | 2023-03-01 | 442 |
| K221351 | Mechanical Guidewire | DQX | 2022-12-19 | 223 |
| K213582 | Epicardial Access System | DYB | 2022-06-30 | 230 |
| K220414 | VersaCross Connect Transseptal Dilator | DYB | 2022-05-09 | 84 |
| K201288 | ExpanSure Large Access Transseptal Dilator | DRE | 2020-06-12 | 29 |
43 earlier clearances. See the full list in Caduvo.
Recalls
9 product recalls in 8 recall events; 0 initiated in the last five years. Most recent: 2019-10-07.
11 product recalls in 4 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 3 initiated in the last five years. Most often: Medtronic Sofamor Danek USA Inc (6), Boston Scientific Corporation (3), Halyard Health, Inc (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Baylis Medical Co., Inc. is the lead sponsor of 4 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT01158092: Trial Comparing Treatment With SInergy™ System to Conservative Treatment for Chronic Sacroiliac Joint Pain (Terminated, started 2010-07)
- NCT00802997: Trial Assessing Cooled Radiofrequency Denervation as a Treatment for Sacroiliac Joint Pain Using the Sinergy System (Completed, started 2008-06)
- NCT00749554: Trial of Disc Biacuplasty to Treat Chronic Discogenic Low Back Pain (Terminated, started 2008-04)
- NCT00750191: Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty (Completed, started 2007-09)
Parent company SEC filings
BOSTON SCIENTIFIC CORP (BSX): EDGAR filings, CIK 885725. Caduvo groups Baylis Medical Co., Inc. under Boston Scientific; the parent's SEC registrant is entered by hand for the group, not matched by name.
FDA spellings included
FDA records this applicant under 3 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Baylis Medical Co., Inc. (28)
- Baylis Medical Company, Inc. (24)
- Baylis Medical Company (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Baylis Medical Technologies, Inc. (5 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Baylis Medical Co., Inc.?
FDA lists 53 510(k) clearances under 3 spellings of the applicant name “Baylis Medical Co., Inc.” (first 1998, latest 2025), across 15 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Baylis Medical Co., Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Baylis Medical Co., Inc. is 100 days. Since 2017: 154 days, versus 111 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Baylis Medical Co., Inc.?
The most frequent FDA product codes under this applicant name are GEI (Electrosurgical, Cutting & Coagulation & Accessories, 11); DYB (Introducer, Catheter, 8); GXI (Probe, Radiofrequency Lesion, 7).
Next steps
- See all 53 Baylis Medical Co., Inc. clearances with predicates and recalls
- Run predicate analysis for product code GEI, Baylis Medical Co., Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.